TP53 and breast carcinoma: In breast cancer, the elevated expression of Akt causes normal breast cells to become neoplasm cells via the dysregulation of the cyclin-dependent kinase (CDK) inhibitor, p2122, and inactivation or mutant to tumor suppressor, p53 protein so that the replication of abnormal DNA is not stopped23.